This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murray, H. W.
Right arrow Articles by Delph-Etienne, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, H. W.
Right arrow Articles by Delph-Etienne, S.

 Previous Article  |  Next Article 

Infection and Immunity, January 2000, p. 288-293, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral Leishmaniasis

Henry W. Murray* and Sharmaine Delph-Etienne

Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021

Received 4 June 1999/Returned for modification 5 August 1999/Accepted 11 October 1999

In experimental visceral leishmaniasis, in which the tissue macrophage is the target, in vivo responsiveness to conventional chemotherapy (pentavalent antimony [Sb]) requires a T-cell-dependent mechanism. To determine if this mechanism involves gamma interferon (IFN-gamma )-induced activation and/or specific IFN-gamma -regulated macrophage leishmanicidal mechanisms (generation of reactive nitrogen or oxygen intermediates, we treated gene-deficient mice infected with Leishmania donovani. In IFN-gamma gene knockout (GKO) mice, Sb inhibited but did not kill intracellular L. donovani (2% killing versus 76% in controls). Sb was active (>94% killing), however, in both inducible nitric oxide synthase (iNOS) knockout (KO) and respiratory burst (phagocyte oxidase)-deficient chronic granulomatous disease (X-CGD) mice. Sb's efficacy was also maintained in doubly deficient animals (X-CGD mice treated with an iNOS inhibitor). In contrast to Sb, amphotericin B (AmB) induced high-level killing in GKO mice; AmB was also fully active in iNOS KO and X-CGD animals. Although resolution of L. donovani infection requires iNOS, residual visceral infection remained largely suppressed in iNOS KO mice treated with Sb or AmB. These results indicate that endogenous IFN-gamma regulates the leishmanicidal response to Sb and achieves this effect via a pathway unrelated to the macrophage's primary microbicidal mechanisms. The role of IFN-gamma is selective, since it is not a cofactor in the response to AmB. Treatment with either Sb or AmB permits an iNOS-independent mechanism to emerge and control residual intracellular L. donovani infection.

* Corresponding author. Mailing address: Box 130, 1300 York Ave., New York, NY 10021. Phone: (212) 746-6330. Fax: (212) 746-6332. E-mail: hwmurray{at}mail.med.cornell.edu.

Infection and Immunity, January 2000, p. 288-293, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Murray, H. W. (2008). Accelerated Control of Visceral Leishmania donovani Infection in Interleukin-6-Deficient Mice. Infect. Immun. 76: 4088-4091 [Abstract] [Full Text]  
  • Murray, H. W., Tsai, C. W., Liu, J., Ma, X. (2006). Responses to Leishmania donovani in Mice Deficient in Interleukin-12 (IL-12), IL-12/IL-23, or IL-18. Infect. Immun. 74: 4370-4374 [Abstract] [Full Text]  
  • Rosas, L. E., Snider, H. M., Barbi, J., Satoskar, A. A., Lugo-Villarino, G., Keiser, T., Papenfuss, T., Durbin, J. E., Radzioch, D., Glimcher, L. H., Satoskar, A. R. (2006). Cutting Edge: STAT1 and T-bet Play Distinct Roles in Determining Outcome of Visceral Leishmaniasis Caused by Leishmania donovani. J. Immunol. 177: 22-25 [Abstract] [Full Text]  
  • MURRAY, H. W., XIANG, Z., MA, X. (2006). RESPONSES TO LEISHMANIA DONOVANI IN MICE DEFICIENT IN BOTH PHAGOCYTE OXIDASE AND INDUCIBLE NITRIC OXIDE SYNTHASE. Am J Trop Med Hyg 74: 1013-1015 [Abstract] [Full Text]  
  • Mookerjee Basu, J., Mookerjee, A., Sen, P., Bhaumik, S., Sen, P., Banerjee, S., Naskar, K., Choudhuri, S. K., Saha, B., Raha, S., Roy, S. (2006). Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation in Leishmania donovani-Infected Macrophages.. Antimicrob. Agents Chemother. 50: 1788-1797 [Abstract] [Full Text]  
  • Murray, H. W., Tsai, C. W., Liu, J., Ma, X. (2006). Visceral Leishmania donovani Infection in Interleukin-13-/- Mice. Infect. Immun. 74: 2487-2490 [Abstract] [Full Text]  
  • Fan, K., Zhou, M., Pathak, M. K., Lindner, D. J., Altuntas, C. Z., Tuohy, V. K., Borden, E. C., Yi, T. (2005). Sodium Stibogluconate Interacts with IL-2 in Anti-Renca Tumor Action via a T Cell-Dependent Mechanism in Connection with Induction of Tumor-Infiltrating Macrophages. J. Immunol. 175: 7003-7008 [Abstract] [Full Text]  
  • Holzmuller, P., Sereno, D., Lemesre, J.-L. (2005). Lower Nitric Oxide Susceptibility of Trivalent Antimony-Resistant Amastigotes of Leishmania infantum. Antimicrob. Agents Chemother. 49: 4406-4409 [Abstract] [Full Text]  
  • Ukil, A., Biswas, A., Das, T., Das, P. K. (2005). 18{beta}-Glycyrrhetinic Acid Triggers Curative Th1 Response and Nitric Oxide Up-Regulation in Experimental Visceral Leishmaniasis Associated with the Activation of NF-{kappa}B. J. Immunol. 175: 1161-1169 [Abstract] [Full Text]  
  • Murray, H. W., Flanders, K. C., Donaldson, D. D., Sypek, J. P., Gotwals, P. J., Liu, J., Ma, X. (2005). Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral Leishmaniasis. Infect. Immun. 73: 3903-3911 [Abstract] [Full Text]  
  • Murray, H. W. (2005). Prevention of Relapse after Chemotherapy in a Chronic Intracellular Infection: Mechanisms in Experimental Visceral Leishmaniasis. J. Immunol. 174: 4916-4923 [Abstract] [Full Text]  
  • Wyllie, S., Cunningham, M. L., Fairlamb, A. H. (2004). Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani. J. Biol. Chem. 279: 39925-39932 [Abstract] [Full Text]  
  • Murray, H. W., Lu, C. M., Brooks, E. B., Fichtl, R. E., DeVecchio, J. L., Heinzel, F. P. (2003). Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis. Infect. Immun. 71: 6453-6462 [Abstract] [Full Text]  
  • Murray, H. W., Brooks, E. B., DeVecchio, J. L., Heinzel, F. P. (2003). Immunoenhancement Combined with Amphotericin B as Treatment for Experimental Visceral Leishmaniasis. Antimicrob. Agents Chemother. 47: 2513-2517 [Abstract] [Full Text]  
  • Colmenares, M., Kima, P. E., Samoff, E., Soong, L., McMahon-Pratt, D. (2003). Perforin and Gamma Interferon Are Critical CD8+ T-Cell-Mediated Responses in Vaccine-Induced Immunity against Leishmania amazonensis Infection. Infect. Immun. 71: 3172-3182 [Abstract] [Full Text]  
  • Ghosh, M., Pal, C., Ray, M., Maitra, S., Mandal, L., Bandyopadhyay, S. (2003). Dendritic Cell-Based Immunotherapy Combined with Antimony-Based Chemotherapy Cures Established Murine Visceral Leishmaniasis. J. Immunol. 170: 5625-5629 [Abstract] [Full Text]  
  • Pathak, M. K., Dhawan, D., Lindner, D. J., Borden, E. C., Farver, C., Yi, T. (2002). Pentamidine Is an Inhibitor of PRL Phosphatases with Anticancer Activity. Molecular Cancer Therapeutics 1: 1255-1264 [Abstract] [Full Text]  
  • Yi, T., Pathak, M. K., Lindner, D. J., Ketterer, M. E., Farver, C., Borden, E. C. (2002). Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs. J. Immunol. 169: 5978-5985 [Abstract] [Full Text]  
  • Murray, H. W., Lu, C. M., Mauze, S., Freeman, S., Moreira, A. L., Kaplan, G., Coffman, R. L. (2002). Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy. Infect. Immun. 70: 6284-6293 [Abstract] [Full Text]  
  • Murray, H. W. (2001). Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis. Antimicrob. Agents Chemother. 45: 2185-2197 [Full Text]  
  • Murray, H. W., Jungbluth, A., Ritter, E., Montelibano, C., Marino, M. W. (2000). Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment. Infect. Immun. 68: 6289-6293 [Abstract] [Full Text]  
  • Murray, H. W. (2000). Mononuclear Cell Recruitment, Granuloma Assembly, and Response to Treatment in Experimental Visceral Leishmaniasis: Intracellular Adhesion Molecule 1-Dependent and -Independent Regulation. Infect. Immun. 68: 6294-6299 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»